Comments on the 2019 ESC/EAS guidelines for the management of dyslipidemias

Rev Esp Cardiol (Engl Ed). 2020 May;73(5):348-353. doi: 10.1016/j.rec.2019.11.019. Epub 2020 Mar 21.

[Article in English, Spanish]

Authors

SEC Working Group for the 2019 ESC EAS guidelines for the management of dyslipidaemias, Expert Reviewers for the 2019 ESC guidelines for the management of dyslipidaemias, SEC Guidelines Committe; Grupo de Trabajo de la SEC para la guía ESC 2019 sobre el tratamiento de las dislipemias; Revisores expertos para la ESC 2019 sobre el tratamiento de las dislipemias; Comité de Guías de la SEC

Collaborators

PMID: 32205101
DOI: 10.1016/j.rec.2019.11.019

No abstract available

Publication types

Editorial
Comment

MeSH terms

Cardiovascular Diseases* / prevention & control
Dyslipidemias* / drug therapy
Heart Disease Risk Factors
Humans
Lipids
Risk Factors

Substances

Lipids